Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion

Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion

Submitted by CP Staff on June 18, 2018 - 9:52am
Source: 
Marketwatch
News Tags: 
Valeant Pharmaceuticals
psoriasis
FDA
Duobrii
Headline: 
Valeant shares drop 5% after FDA fails to approve plaque psoriasis lotion
snippet: 

Valeant Pharmaceuticals International said on Monday that U.S. health regulators had declined to approve its lotion to treat plaque psoriasis.

Do Not Allow Advertisers to Use My Personal information